共 30 条
Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections
被引:13
作者:
Verweij, Stephan P.
[1
]
Lanjouw, Esmee
[2
]
Bax, Caroline J.
[3
,4
]
Quint, Koen D.
[5
,6
]
Oostvogel, Paul M.
[7
]
Dorr, P. Joep
[3
]
Pleijster, Jolein
[1
]
de Vries, Henry J. C.
[8
,9
,10
]
Peters, Remco P. H.
[11
,12
]
Ouburg, Sander
[1
]
Morre, Servaas A.
[1
,13
]
机构:
[1] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Immunogenet Lab, NL-1081 HV Amsterdam, Netherlands
[2] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
[3] MC Haaglanden Hosp, Dept Obstet & Gynecol, The Hague, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Obstet, Amsterdam, Netherlands
[5] DDL Diagnost Lab, Rijswijk, Netherlands
[6] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands
[7] MC Haaglanden Hosp, Dept Med Microbiol, The Hague, Netherlands
[8] Publ Hlth Serv Amsterdam, STI Outpatient Clin Cluster Infect Dis, Amsterdam, Netherlands
[9] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
[10] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands
[11] Hague Municipal Hlth Serv, The Hague, Netherlands
[12] Anova Hlth Inst, Khutso Kurhula Off, Tzaneen, South Africa
[13] Univ Maastricht, Fac Hlth Med & Life Sci, Inst Publ Hlth Genom, Res Inst GROW,Dept Genet & Cell Biol, Maastricht, Netherlands
来源:
BMC INFECTIOUS DISEASES
|
2014年
/
14卷
关键词:
Chlamydia trachomatis;
Serological response;
Serovar;
Serogroup;
IgG;
Antibodies;
CLINICAL-MANIFESTATIONS;
OCULOGENITAL SEROVARS;
NATURAL COURSE;
FOLLOW-UP;
WOMEN;
OMP1;
GENE;
SPECIMENS;
VIRULENCE;
STRAINS;
D O I:
10.1186/1471-2334-14-3
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Background: Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) worldwide. A strong link between C. trachomatis serogroup/serovar and serological response has been suggested in a previous preliminary study. The aim of the current study was to confirm and strengthen those findings about serological IgG responses in relation to C. trachomatis serogroups and serovars. Methods: The study population (n = 718) consisted of two patient groups with similar characteristics of Dutch STI clinic visitors. We performed genotyping of serovars and used titre based and quantitative commercially available ELISA kits (medac Diagnostika) to determine specific serum IgG levels. Optical density (OD) values generated by both tests were used to calculate the IgG titres (cut-off 1: 50). Analyses were conducted stratified by gender. Results: We observed very significant differences when comparing the median IgG titres of three serogroups, B, C and I: in women for B vs. C: p < 0.0001 (median titres B 200 vs. C < 50); B vs. I: p < 0.0001 (200 vs. 50), and in men for B vs. C: p = 0.0006 (150 vs. < 50); B vs. I: p = 0.0001 (150 vs. < 50); C vs. I was not significant for both sexes. Serovars D and E of serogroup B had the highest median IgG titres compared to the other serovars in both men and women: 200 and 200 vs. <= 100 for women and 100 and 200 vs. <= 75 for men, respectively. Conclusions: This study shows that B group serovars induce higher serological responses compared to the C and I group serovars in vivo in both men and women.
引用
收藏
页数:7
相关论文